AUG 13, 2026 · JOURNAL ARTICLE
Cost-Effectiveness Analysis of Menopausal Hormone Therapy
Obstetrics and Gynecology
A decision-analytic model with sound methodology and clear results, but modelling studies do not directly measure clinical outcomes and depend heavily on input assumptions; findings require validation in prospective trials.
Reported
Lifetime cost difference, E2 vs n…$135,396,560 less expensive
QALYs gained, E2 vs no MHT per 10…33,196
ASCVD cases prevented, E2 vs no M…259